Rib deposits are frequently missed in the early stages. They may be mistaken for intrapulmonary deposits or localized pleural thickening, tomography often revealing bone lesions not visible on the chest film. Punctate calcification occurs rarely in pulmonary Hodgkin's disease and invariably this is after radiotherapy. Massive lymphatic spread from the mediastinum may be simulated by post-irradiation fibrosis; the writer believes that the latter often shows the linear element to be more vertical at either pole of the shadowing, and that vertical striation is not seen in lymphatic spread.
Finally, a plea is made for the greater recognition of the fungi as a complication of Hodgkin's disease. The aspergillus is the most common fungus causing pulmonary shadows but it seems likely that some cases of severe monilia can cause small transient shadows in the lung fields. Fifty-five patients, who were admitted to the M D Anderson Hospital from January 1950 through December 1965, were treated by radiation therapy for Hodgkin's disease clinically localized to the mediastinum (Stage I) or the mediastinum and the peripheral node-bearing areas above the diaphragm, i.e. the neck and axillk (Stage II). Twenty-six patients, admitted through 1961, have been followed a minimum of five years. Although the same system of staging was employed (Rosenberg & Kaplan 1966) , the material for the periods before and after 1961 was not strictly comparable. Prior to 1961, staging was based on the distribution of enlarged nodes found on physical examination, and on the chest X-ray. Special investigative procedures, such as gastrointestinal series, and intravenous pyelography, were reserved for abdominal symptomatology. In 1961, abdominal (lower extremity) lymphangiography was introduced as a routine investigative procedure for staging and management. ' This investigation was supported in part by Public Health Service Grants CA 06297 and CA 05654.
Staging (Kaplan) Stage I: Disease involves a single lymphatic region. Stage II: Disease involves two or more lymphatic regions above or below the diaphragm. Stage III: Disease involves lymphatic regions above and below the diaphragm. Stage IV: Disease has spread beyond the lymphatic system to liver, bone marrow, lung, skin, central nervous system, &c.
Clinical Features
Contrary to the usual bimodal age distribution found in Hodgkin's disease, 54 of the 55 patients were under 50 years of age, (34 females and 21 males). With the exception of 2 cases of isolated mediastinal adenopathy, all the patients had some combination of mediastinal, cervical and occasionally axillary lymphadenopathy (Stage 1I). A review of the initial, as well as all subsequent radiographs of the chest demonstrated the involvement to be radiographically limited to the anterior superior mediastinum in 26, and to the entire anterior mediastinum in 3. One or both hila were additionally involved in 22. In 4, the disease had extended to the parabronchial lymph nodes.
Regardless of the extent of disease, the incidence of constitutional or local symptomatology was low. Three patients had significant constitutional symptoms. One had evidence of mediastinal compression. Pathology: In all 55 cases, the diagnosis of Hodgkin's disease was established on admission. In 51, sufficient material was available for reclassification according to the method of Lukes & Butler (1966) as follows: Hodgkin's disease with nodular sclerosis 46, with mixed cellularity 4, and with lymphoid predominance 1. Treatment Intensive regional irradiation was administered to the neck, mediastinum, and when necessary the axille, in 48 of the 55 patients. Seven were treated less radically. Prior to 1956, treatment was delivered with kilovoltage. From 1956 through 1959, 250 kilovolt irradiation was gradually superceded by cobalt 60. After 1960, all patients were treated with cobalt 60.
Techniques: After an initial period following the introduction of cobalt 60, carry-over techniques from the kilovoltage era, in which the neck, mediastinum, and axillee were treated as separate regions, were gradually replaced, first, by the 'extended' field, designed to cover the neck and mediastinum in continuity, and later by the 'mantle' which includes the axille (Figs IA, B , 2).
Tumour dose: Kilovoltage: Ten of 17 patients treated with kilovoltage received fairly intensive regional irradiation therapy (3,000 rads tumour dose delivered at a rate of 600 to 750 rads per week). In 5 adults, whose disease was arbitrarily considered too extensive to warrant radical therapy, and in 2 children, treatment was minimal in one, and semi-radical in 6.
Megavoltage: Of 38 patients treated with cobalt 60, the mid-line tumour dose was 3,000 rads in 4; 4,000 in 27; 4,500 in 6; and 5,000 in one. Treatment was administered at a rate of 1,000 rads per week.
In a few instances, an additional tumour dose of 500 rads was administered for residual disease through very sharply reduced fields.
Results: The results of the radiotherapeutic management of Hodgkin's disease of the mediastinum (Stages I and IL) have been reviewed from the standpoint of survival, local control, and complications. The survival rates for three, five and ten years, calculated according to the Modified Life Method of Berkson Gage, were 95 5, 78-4 and 56-5 %. Of 10 patients who developed recurrence in the mediastinum, 5 were adults who received less than adequate treatment. Another 4, who were treated radically, died within three to four years of a relentlessly progressive local and generalized disease. One woman developed a mediastinal recurrence thirteen years following thoracotomy and radical irradiation (3,000 rads tumour dose delivered in four weeks). In addition to mediastinal recurrence, all 10 of these patients had evidence of associated involvement of the pulmonary parenchyma and/or pleura. Two additional patients, with no evidence of recurrence in the mediastinum proper, developed a marginal parahilar mass.
With the exception of one patient who developed a paraplegia following retreatment for a local recurrence, no serious complications developed as a result of mediastinal treatment. How-ever, a review of serial follow-up radiographs of the chest demonstrated an increasing incidence of paramediastinal fibrosis for tumour doses above 3,000 rads. Doses above 4,000 rads, delivered to the entire mediastinum, are not recommended because of the very pronounced degree of residual fibrosis.
